Brief: Janux Therapeutics Announces First Patient Dosed In Phase 1 Study Of Janx011
17/02/2026 12:26
Feb 17 (Reuters) - Janux Therapeutics Inc JANX.O: JANUX THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 STUDY OF JANX011 Source text: ID:nBwbGqfRGa Further company coverage: JANX.O ((Reuters.Briefs@thomsonreuters.com;))